TY - JOUR
T1 - LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression
AU - Chiyoda, Tatsuyuki
AU - Sugiyama, Naoyuki
AU - Shimizu, Takatsune
AU - Naoe, Hideaki
AU - Kobayashi, Yusuke
AU - Ishizawa, Jo
AU - Arima, Yoshimi
AU - Tsuda, Hiroshi
AU - Ito, Masaaki
AU - Kaibuchi, Kozo
AU - Aoki, Daisuke
AU - Ishihama, Yasushi
AU - Saya, Hideyuki
AU - Kuninaka, Shinji
PY - 2012/5
Y1 - 2012/5
N2 - In the mitotic exit network of budding yeast, Dbf2 kinase phosphorylates and regulates Cdc14 phosphatase. In contrast, no phosphatase substrates of LATS1/WARTS kinase, the mammalian equivalent of Dbf2, has been reported. To address this discrepancy, we performed phosphoproteomic screening using LATS1 kinase. Screening identified MYPT1 (myosin phosphatase- targeting subunit 1) as a new substrate for LATS1. LATS1 directly and preferentially phosphorylated serine 445 (S445) of MYPT1. An MYPT1 mutant (S445A) failed to dephosphorylate Thr 210 of PLK1 (pololike kinase 1), thereby activating PLK1. This suggests that LATS1 promotes MYPT1 to antagonize PLK1 activity. Consistent with this, LATS1-depleted HeLa cells or fibroblasts from LATS1 knockout mice showed increased PLK1 activity. We also found deoxyribonucleic acid (DNA) damage-induced LATS1 activation caused PLK1 suppression via the phosphorylation of MYPT1 S445. Furthermore, LATS1 knockdown cells showed reduced G2 checkpoint arrest after DNA damage. These results indicate that LATS1 phosphorylates a phosphatase as does the yeast Dbf2 and demonstrate a novel role of LATS1 in controlling PLK1 at the G2 DNA damage checkpoint.
AB - In the mitotic exit network of budding yeast, Dbf2 kinase phosphorylates and regulates Cdc14 phosphatase. In contrast, no phosphatase substrates of LATS1/WARTS kinase, the mammalian equivalent of Dbf2, has been reported. To address this discrepancy, we performed phosphoproteomic screening using LATS1 kinase. Screening identified MYPT1 (myosin phosphatase- targeting subunit 1) as a new substrate for LATS1. LATS1 directly and preferentially phosphorylated serine 445 (S445) of MYPT1. An MYPT1 mutant (S445A) failed to dephosphorylate Thr 210 of PLK1 (pololike kinase 1), thereby activating PLK1. This suggests that LATS1 promotes MYPT1 to antagonize PLK1 activity. Consistent with this, LATS1-depleted HeLa cells or fibroblasts from LATS1 knockout mice showed increased PLK1 activity. We also found deoxyribonucleic acid (DNA) damage-induced LATS1 activation caused PLK1 suppression via the phosphorylation of MYPT1 S445. Furthermore, LATS1 knockdown cells showed reduced G2 checkpoint arrest after DNA damage. These results indicate that LATS1 phosphorylates a phosphatase as does the yeast Dbf2 and demonstrate a novel role of LATS1 in controlling PLK1 at the G2 DNA damage checkpoint.
UR - http://www.scopus.com/inward/record.url?scp=84862591602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862591602&partnerID=8YFLogxK
U2 - 10.1083/jcb.201110110
DO - 10.1083/jcb.201110110
M3 - Article
C2 - 22641346
AN - SCOPUS:84862591602
SN - 0021-9525
VL - 197
SP - 625
EP - 641
JO - Journal of Cell Biology
JF - Journal of Cell Biology
IS - 5
ER -